396 related articles for article (PubMed ID: 24469954)
1. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
[TBL] [Abstract][Full Text] [Related]
2. NEDD9 overexpression correlates with poor prognosis in gastric cancer.
Liu Y; Wang D; Zhao KL; Zhu JW; Yin HB; Wei YZ; Wu ZJ; Cheng GJ; Wang F; Ni F; Wang XL; Cao GX; Huang J; Cai J
Tumour Biol; 2014 Jul; 35(7):6351-6. PubMed ID: 24664584
[TBL] [Abstract][Full Text] [Related]
3. Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas.
Xu XY; Gou WF; Yang X; Wang GL; Takahashi H; Yu M; Mao XY; Takano Y; Zheng HC
Tumour Biol; 2012 Dec; 33(6):1845-54. PubMed ID: 22948776
[TBL] [Abstract][Full Text] [Related]
4. Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance.
Xue YZ; Sheng YY; Liu ZL; Wei ZQ; Cao HY; Wu YM; Lu YF; Yu LH; Li JP; Li ZS
Tumour Biol; 2013 Apr; 34(2):895-9. PubMed ID: 23247867
[TBL] [Abstract][Full Text] [Related]
5. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC
Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Nedd9 is a prognostic marker of human gastric cancer.
Zhang Q; Wang H; Ma Y; Zhang J; He X; Ma J; Zhao ZS
Med Oncol; 2014 Jul; 31(7):33. PubMed ID: 24906654
[TBL] [Abstract][Full Text] [Related]
7. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z
World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma.
Hu X; Xin Y; Xiao Y; Zhao J
Pathol Oncol Res; 2014 Oct; 20(4):805-11. PubMed ID: 24643316
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.
Ertao Z; Jianhui C; Kang W; Zhijun Y; Hui W; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C
Tumour Biol; 2016 Oct; 37(10):13679-13685. PubMed ID: 27473085
[TBL] [Abstract][Full Text] [Related]
10. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
[TBL] [Abstract][Full Text] [Related]
11. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
[TBL] [Abstract][Full Text] [Related]
12. Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer.
Kwon CH; Park HJ; Lee JR; Kim HK; Jeon TY; Jo HJ; Kim DH; Kim GH; Park DY
Br J Cancer; 2014 Nov; 111(10):1993-2002. PubMed ID: 25211665
[TBL] [Abstract][Full Text] [Related]
13. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
14. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
15. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
[TBL] [Abstract][Full Text] [Related]
16. Expression of NEDD9 in hepatocellular carcinoma and its clinical significance.
Lu P; Wang ZP; Dang Z; Zheng ZG; Li X; Zhou L; Ding R; Yue SQ; Dou KF
Oncol Rep; 2015 May; 33(5):2375-83. PubMed ID: 25812772
[TBL] [Abstract][Full Text] [Related]
17. DIMT1 overexpression correlates with progression and prognosis in gastric carcinoma.
Liu G; Peng X; Cai Y; Cheng A; Zha L; Wang Z
Hum Pathol; 2017 Dec; 70():35-42. PubMed ID: 28601661
[TBL] [Abstract][Full Text] [Related]
18. Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.
Luo D; Huang H; Lu ML; Zhao GF; Chang J; Zheng MY; Wang Y
Pathol Oncol Res; 2012 Apr; 18(2):491-7. PubMed ID: 22109561
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of SLP-2 correlate with poor prognosis in gastric cancer.
Liu D; Zhang L; Shen Z; Tan F; Hu Y; Yu J; Li G
Gastric Cancer; 2013 Oct; 16(4):498-504. PubMed ID: 23371255
[TBL] [Abstract][Full Text] [Related]
20. Lysyl oxidase-like 4 (LOXL4) promotes proliferation and metastasis of gastric cancer via FAK/Src pathway.
Li RK; Zhao WY; Fang F; Zhuang C; Zhang XX; Yang XM; Jiang SH; Kong FZ; Tu L; Zhang WM; Yang SL; Cao H; Zhang ZG
J Cancer Res Clin Oncol; 2015 Feb; 141(2):269-81. PubMed ID: 25216702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
